Everything tagged "ipo" across the TickerSpark archives.
Einride AB American Depositary Shares are expected to list on NASDAQ on 2026-06-10 under ticker ENRD, but the price range has not been disclosed. The deal is a SPAC business combination with Legato Merger Corp. III, so the key watch item is how the market values a capital-intensive autonomy story with real revenue but heavy execution risk.
First Carolina Financial Services, Inc. (NYSE: FCBM) is expected to list on 2026-06-18 at a price range of $14.00 to $16.00 per share. The offering includes 5,500,000 shares, with a disclosed market cap of about $101.2 million. The bull case is a profitable Southeast bank with a payments and wealth platform; the bear case is the usual bank mix of rate sensitivity, credit risk, and heavy competition for deposits.
Bitzero Holdings Inc. Common Shares (NASDAQ: AIBZ) is expected to list on 2026-06-09, but the price range has not been disclosed. The setup is a classic bull-bear split: renewable-powered data-center growth and AI/HPC exposure on one side, ongoing losses and crypto volatility on the other.
Veraxa Biotech AG Ordinary Shares (NASDAQ: VRXA) is expected to list on 2026-06-10, but the price range has not been disclosed. This is a SPAC business combination rather than a traditional IPO, with the story centered on a pre-commercial oncology pipeline. Bull case: a differentiated antibody-therapy platform; bear case: no product revenue yet and heavy financing needs.
Eloxx Pharmaceuticals, Inc. (NASDAQ: ELOX) is expected to list on 2026-06-09, but the price range has not been disclosed. The company is a clinical-stage biotech, so the key question is whether investors are willing to fund a thin pipeline and a going-concern story. The setup favors traders watching for financing support and clinical execution, while shareholders should watch dilution risk closely.
Fort Technology Inc. Common Shares (NASDAQ: FRTT) is expected to list on 2026-06-08, but the price range has not been disclosed. The company is a small Amazon-first pest control CPG business with a Europe-heavy footprint and a future U.S. expansion plan. The bull case is marketplace execution; the bear case is dependence on Amazon, thin scale, and ongoing capital needs.
Parabilis Medicines (NASDAQ: PBLS) is expected to list on 2026-06-10, with shares priced at $17.00 to $19.00. The company is offering 25,000,000 shares and is targeting a $546,250,000 market cap. The bull case is a differentiated oncology platform; the bear case is a clinical-stage biotech with no disclosed commercial revenue.
FutureCorp Space Acquisition 1 is expected to list on the NYSE on 2026-06-05 under FTRAU, with a price range of $10.00 per unit. The SPAC is offering 20,000,000 units, implying $200.0 million in gross proceeds. The setup is straightforward: the sponsor is aiming at the space economy and defense-adjacent infrastructure, but the company has not yet selected a target. Shareholders should watch for target quality, deal structure, and how much dilution comes with the eventual business combination.
Space Exploration Technologies Corp. (SPCX) is expected to list on NASDAQ on 2026-06-12. The company has not disclosed a price range or share count yet. The setup is all about whether Starlink’s scale and the new AI compute push can outweigh heavy launch and infrastructure risk.
INNIO N.V. Ordinary Shares is expected to list on NASDAQ on 2026-06-04 under the symbol INIO, with a price range not yet disclosed. The IPO is for 75,000,000 shares and carries a disclosed market cap of $2,328,750,000. The setup leans on AI/data-center power demand, but investors should watch the fact that this is a secondary-only deal with no new capital going to the company.
Forbright, Inc. (NASDAQ: FRBT) is expected to list on June 11, 2026, on the Nasdaq at a price range of $18.00 to $20.00 per share. The deal is sized at 7,900,000 shares, with a disclosed market cap of $181,700,000. The bull case is a founder-led bank with strong asset growth and a differentiated digital deposit and middle-market lending model. The bear case is that it is still a bank IPO in a selective market, so credit quality, funding costs, and valuation will matter a lot.
Lannister Mining Corp. is expected to list on the NYSE on 2026-06-05, but the price range has not been disclosed yet. The company is a Vancouver-headquartered, Canada-incorporated mineral exploration and development play focused on the Basin Gulch Project in Montana. Bull case: a near-surface, primarily oxide gold-and-silver project can be attractive if the geology and economics hold up. Bear case: with no pricing, no share count, and limited operating disclosure, investors are still being asked to underwrite a very early-stage story.
Generate AI research on any ticker — grades, price targets, and full analysis in minutes.
Open the GeneratorCancel anytime